Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
Creator
Ang, Brenda
Ksiazek, Thomas
Oon, Lynette
Yeo, Daniel
Chan, Kwai
Khan, Ali
Leo, Yee
Ling, Ai
Bai, Xin
Hoe, Nam
Leong,
Se-Thoe, Yun
source
Medline; PMC
abstract
Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV). In a longitudinal cross-sectional study, we determined the prevalence of virus in bodily excretions and time of seroconversion in discharged patients with SARS. Conjunctival, throat, stool, and urine specimens were collected weekly from 64 patients and tested for SARS-CoV RNA by real-time polymerase chain reaction; serum samples were collected weekly and tested for SARS-CoV antibody with indirect enzyme immunoassay and immunofluorescence assay. In total, 126 conjunctival, 124 throat swab, 116 stool, and 124 urine specimens were analyzed. Five patients had positive stool samples, collected in weeks 5–9. Two patients seroconverted in weeks 7 and 8; the others were seropositive at the first serum sample collection. In this study, 5 (7.8%) of 64 patients continued to shed viral RNA in stool samples only, for up to week 8 of illness. Most seroconversions occurred by week 6 of illness.
has issue date
2004-10-01
(
xsd:dateTime
)
bibo:doi
10.3201/eid1010.040026
bibo:pmid
15504259
has license
no-cc
sha1sum (hex)
80d9d5734676b9a27d165dbb2826d4ba1da23da5
schema:url
https://doi.org/10.3201/eid1010.040026
resource representing a document's title
Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
has PubMed Central identifier
PMC3323266
has PubMed identifier
15504259
schema:publication
Emerg Infect Dis
resource representing a document's body
covid:80d9d5734676b9a27d165dbb2826d4ba1da23da5#body_text
is
schema:about
of
named entity 'seroconversion'
named entity 'virus'
named entity 'cross-sectional study'
named entity 'serum'
named entity 'stool'
named entity 'patients'
named entity 'throat swab'
named entity '124'
named entity 'WEEKS'
named entity 'SEVERE ACUTE RESPIRATORY SYNDROME'
named entity 'CROSS-SECTIONAL STUDY'
named entity 'PREVALENCE'
named entity 'THROAT SWAB'
named entity 'DISCHARGED PATIENTS'
named entity 'PATIENTS'
named entity 'LONGITUDINAL'
named entity 'SARS-COV'
named entity 'REAL-TIME POLYMERASE CHAIN REACTION'
named entity 'NOVEL CORONAVIRUS'
covid:arg/80d9d5734676b9a27d165dbb2826d4ba1da23da5
named entity 'STOOL'
named entity 'POSITIVE'
named entity 'BODILY'
named entity 'ENZYME IMMUNOASSAY'
named entity 'WEEKLY'
named entity 'SEROCONVERSION'
named entity 'COLLECTED'
named entity 'CAUSED BY'
named entity 'TESTED FOR'
named entity 'DETERMINED'
named entity 'STUDY'
named entity 'CONTINUED'
named entity 'CONJUNCTIVAL'
named entity 'ANTIBODY'
named entity 'SEROPOSITIVE'
named entity '287'
named entity '5-9'
named entity 'SARS'
named entity 'WEEK'
named entity 'SAMPLES'
named entity 'RNA'
named entity 'SPECIMENS'
named entity '126'
named entity 'TIME'
named entity 'SERUM SAMPLE'
named entity 'SERUM'
named entity 'ANALYZED'
named entity 'THROAT'
named entity 'OCCURRED'
named entity 'SAMPLE COLLECTION'
named entity 'TOTAL'
named entity 'UP TO'
named entity 'URINE'
named entity '116'
named entity 'INDIRECT'
named entity 'VIRUS'
named entity 'IMMUNOFLUORESCENCE ASSAY'
named entity 'ILLNESS'
named entity 'VIRAL RNA'
named entity 'EXCRETIONS'
named entity 'Severe acute respiratory syndrome (SARS)'
named entity 'continued'
named entity 'Two'
named entity 'seroconverted'
named entity 'weekly'
named entity 'collection'
named entity 'total'
named entity 'time'
named entity 'urine'
named entity 'Conjunctival'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 6
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software